Glaucoma: Honest Answers to the Questions Patients Actually Ask

patient-information- understanding glaucoma, best glaucoma specialist in gurgaon dr shibal bhartiya

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google. Here, she answers some common questions patients have asked her over her clinical practice.

My vision is fine. Why do I still need treatment?

 
Treatment is not about how you see today, it is about protecting how you will see years from now.
 

The goal is stability, not crisis management.

 
If glaucoma has no symptoms, how serious is it really?
 
Glaucoma is serious precisely because it is silent. Once vision loss occurs, it cannot be reversed, which is why early, consistent care matters more than waiting for symptoms.
 
 

Can glaucoma exist even if my eye pressure is normal?

Yes. This is called normal-tension glaucoma. Eye pressure is only one risk factor. Optic nerve structure, blood flow, corneal thickness, and individual susceptibility all matter. This is why glaucoma assessment should never rely on pressure alone.

My OCT is normal, does that rule out glaucoma?

Not completely. OCT scans are very useful, but early damage can be subtle, asymmetric, or masked by individual anatomical variation. OCT results are most meaningful when interpreted over time, alongside optic nerve examination and visual fields.

If my visual fields are normal, why am I being asked to follow up?

Because structural damage often precedes functional loss in glaucoma. Visual fields may remain normal until a significant number of nerve fibres are already lost. Follow-up helps detect change early, when vision can still be protected.

Am I overthinking this if all my reports say “normal”?

Not necessarily. Feeling uncertain despite normal tests often means you need a clearer explanation of what has been ruled out, what hasn’t, and how your eyes should be monitored over time. A good glaucoma consultation should reduce fear, not dismiss it. 

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions.

Will I need treatment for life?

 
In most cases, yes. Glaucoma is usually a long-term condition, and treatment works best when it is steady and boring, not reactive.
 
That said, treatment plans are adjusted over time based on how your eyes respond.
 
⸻
 

What happens if I miss my drops occasionally?

 
Missing drops once in a while happens, but repeated gaps increase the risk of damage over time.
 
If drops are difficult to use or remember, it’s important to discuss this openly.
There are alternatives, and the plan should fit your life.
 
⸻
 

Is glaucoma always progressive?

 
Not always, and this is an important point.
 
With early detection and appropriate treatment, many people maintain stable vision for life.
Progression is more likely when diagnosis or treatment is delayed.
 
⸻
 

How often do I really need to be reviewed?

 
Follow-up frequency depends on:
•the type of glaucoma
•eye pressure levels
•optic nerve health
•rate of change over time
 
For some, this means a few visits a year; for others, closer monitoring. Regular review is what allows care to stay preventive rather than urgent.
 
⸻
 

Are eye drops the only option?

 
No.
 
Treatment options may include:
•eye drops
•laser treatment
•surgery (when needed)
 
The right option depends on risk, stage, and response, not a one-size-fits-all approach.
 
⸻
 

Can lifestyle changes cure glaucoma?

 
Lifestyle choices support overall eye health, but they do not replace medical treatment.
 
Think of treatment as the foundation; lifestyle measures are supportive, not curative.

My glaucoma tests are normal, but I’m still worried. What should I do?

It’s common to feel worried even when glaucoma tests are reported as “normal.” Early glaucoma does not always show up clearly on a single test, and structural changes in the optic nerve can sometimes precede measurable visual field loss.

If you remain concerned, it’s reasonable to consult a fellowship-trained glaucoma specialist who focuses on early detection and long-term risk assessment rather than treating only advanced disease.

The tests included in a comprehensive glaucoma review inclde:

  • Optic nerve structure and asymmetry
  • OCT scans interpreted in context (not in isolation)
  • Eye pressure patterns over time
  • Corneal thickness and individual risk factors
  • Family history and subtle functional symptoms

Is glaucoma hereditary? Should my family be checked?

 
Yes, family members, especially first-degree relatives, should be screened.
 
Glaucoma often runs in families, and early checks can prevent late discovery.
 
⸻
 

What should I bring to my consultation?

 
If available:
•previous eye reports
•test results
•medication list
 
If not, don’t worry.
What matters most is an honest conversation and a clear plan.
 
⸻
 

What is the goal of glaucoma care?

 
Not perfect numbers.
Not aggressive treatment.
 
The goal is long-term stability, preserved vision, and a plan you can live with; quietly, consistently, and safely.
 
 
 
If you have concerns that aren’t answered here, it’s okay to ask. Good glaucoma care is not rushed, and it is not one-directional. If you would like a structured second opinion or long-term care plan, you can request one through the website.
 

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

These peer-reviewed article discussing glaucoma treatment can be accessed on PubMed here, here, here, here, here, here, here, and here

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.